Immune Resolution After Staphylococcus Aureus Bacteremia

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to determine how monocyte HLA-DR and other markers of immune function change with time in patients with and without prior immune dysfunction who survive sepsis from Staphylococcus aureus bacteremia. We hypothesize that patients with prior immune dysfunction will have greater reductions in HLA-DR and other markers of immune function after an episode of sepsis than people who do not have prior immune dysfunction.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01879761
Study type	Observational
Source	University of Chicago
Contact
Status	Active, not recruiting
Phase
Start date	June 2013
Completion date	June 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04210505` - Nasal Decolonization of Dialysis Patients Noses	Phase 4
Not yet recruiting	`NCT05361135` - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia	N/A
Completed	`NCT02804711` - A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults	Phase 1
Completed	`NCT02282605` - Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects	Phase 1/Phase 2
Recruiting	`NCT06319235` - Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®	Phase 1/Phase 2
Enrolling by invitation	`NCT06317688` - Effectiveness of Highly Purified Anhydrous (HPA) Lanolin Versus Extra-Virgin Coconut Oil in Preventing Subacute Lactation Mastitis	Phase 1
Withdrawn	`NCT02741869` - Photodisinfection for the Decolonization of Staphylococcus Aureus in Hemodialysis Patients	N/A
Completed	`NCT03966040` - A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults	Phase 1
Completed	`NCT04803708` - Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers	Phase 1/Phase 2
Recruiting	`NCT05117398` - Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus	Phase 3
Completed	`NCT02820883` - A Study of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults	Phase 0
Completed	`NCT01375621` - Livestock Contact and MRSA in Rural Areas
Recruiting	`NCT00532324` - Community-Acquired Methicillin Resistant Staphylococcus Aureus Colonization in Pregnant Women and Infections in Newborns	N/A
Completed	`NCT04503252` - Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus
Recruiting	`NCT06368856` - Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric Study	Phase 1
Not yet recruiting	`NCT05899140` - Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial	Phase 4
Completed	`NCT01792804` - Staphylococcus Aureus Bacteremia Antibiotic Treatment Options	Phase 3
Enrolling by invitation	`NCT04897971` - Serum Based Diagnosis of and Monitoring of Infection Recovery in Orthopedic Spine Implant Infections
Completed	`NCT00572910` - A Study to Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis (V710-005)(COMPLETED)	Phase 2
Recruiting	`NCT04712123` - Recurrent S. Aureus Infections in Osteoarticular Infections